Evidence map›Paper›PMID 40149919›Full record

ReviewBiomolecules2025

The Association Among Bipolar Disorder, Mitochondrial Dysfunction, and Reactive Oxygen Species.

Yuki Kageyama, Shohei Okura, Ayaka Sukigara, Ayaka Matsunaga, Kunio Maekubo, Takafumi Oue, Koki Ishihara, Yasuhiko Deguchi, Koki Inoue

Abstract readReview
In one paragraph

Review in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuki KageyamaDepartment of Neuropsychiatry, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan.ORCID 0000-0002-9496-9204
Shohei OkuraDepartment of Neuropsychiatry, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan.
Ayaka SukigaraDepartment of Neuropsychiatry, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan.
Ayaka MatsunagaDepartment of Neuropsychiatry, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan.
Kunio MaekuboDepartment of Neuropsychiatry, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan.
Takafumi OueDepartment of Neuropsychiatry, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan.
Koki IshiharaDepartment of Neuropsychiatry, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan.
Yasuhiko DeguchiDepartment of Neuropsychiatry, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan.
Koki InoueDepartment of Neuropsychiatry, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan.ORCID 0000-0003-3044-3921

Funding

Japan Society for the Promotion of Science KAKENHI 22K21150 and 23K14804
6 · The paper itself

Abstract

Mitochondria, often known as the cell's powerhouses, are primarily responsible for generating energy through aerobic oxidative phosphorylation. However, their functions extend far beyond just energy production. Mitochondria play crucial roles in maintaining calcium balance, regulating apoptosis (programmed cell death), supporting cellular signaling, influencing cell metabolism, and synthesizing reactive oxygen species (ROS). Recent research has highlighted a strong link between bipolar disorder (BD) and mitochondrial dysfunction. Mitochondrial dysfunction contributes to oxidative stress, particularly through the generation of ROS, which are implicated in the pathophysiology of BD. Oxidative stress arises when there is an imbalance between the production of ROS and the cell's ability to neutralize them. In neurons, excessive ROS can damage various cellular components, including proteins in neuronal membranes and intracellular enzymes. Such damage may interfere with neurotransmitter reuptake and the function of critical enzymes, potentially affecting brain regions involved in mood regulation and emotional control, which are key aspects of BD. In this review, we will explore how various types of mitochondrial dysfunction contribute to the production of ROS. These include disruptions in energy metabolism, impaired ROS management, and defects in mitochondrial quality control mechanisms such as mitophagy (the process by which damaged mitochondria are selectively degraded). We will also examine how abnormalities in calcium signaling, which is crucial for synaptic plasticity, can lead to mitochondrial dysfunction. Additionally, we will discuss the specific mitochondrial dysfunctions observed in BD, highlighting how these defects may contribute to the disorder's pathophysiology. Finally, we will identify potential therapeutic targets to improve mitochondrial function, which could pave the way for new treatments to manage or mitigate symptoms of BD.

Indexed as

Bipolar DisorderMitochondriaReactive Oxygen SpeciesAnimalsCalcium SignalingEnergy MetabolismHumansMitophagyOxidative StressReactive Oxygen Speciesbipolar disorderinflammationmitophagyreactive oxygen speciessynaptic plasticity

Identifiers

PMID40149919
PMCPMC11940798

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.